New approaches to the diagnosis and treatment of coagulation disorders
- Authors: Shibeko A.M.1,2, Balandina A.N.1,2, Panteleev M.A.1,2
- 
							Affiliations: 
							- Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
 
- Issue: Vol 19, No 4 (2020)
- Pages: 243-250
- Section: LITERATURE REVIEW
- Submitted: 22.12.2020
- Accepted: 22.12.2020
- Published: 08.07.2025
- URL: https://hemoncim.com/jour/article/view/440
- DOI: https://doi.org/10.24287/1726-1708-2020-19-4-243-250
- ID: 440
Cite item
Full Text
Abstract
With the advent of new approaches in coagulation studies capable of identifying regulatory mechanisms involved in transport processes, the spatial localization of processes and interaction between the coagulation system and the immune system, the complement system, and fibrinolysis, the existing diagnostic and treatment approaches used in clinical and laboratory practice are changing as well. This review describes modern diagnostic methods for hemostasis disorders that are based on an integrative approach and are used to assess many aspects of the coagulation system at once. The reviewed methods are sensitive not only to bleeding but also to prothrombotic states, and enable monitoring of treatment with various medications including both oral anticoagulants and antihemophilic agents. We will also cover new approaches to the treatment of hemostasis disorders made possible by the understanding of the involved control mechanisms, such as the use of bispecific antibodies as an alternative to coagulation cofactors, the inhibition of inhibitors and the development of new drug delivery techniques.
About the authors
A. M. Shibeko
Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
							Author for correspondence.
							Email: alshibeko@gmail.com
				                	ORCID iD: 0000-0003-1494-3125
				                																			                								
Alexey М. Shibeko, PhD, leading researcher, laboratory of biophysics
1 Samory Mashela St., Moscow 117997
Russian FederationA. N. Balandina
Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian FederationMoscow Russian Federation
M. A. Panteleev
Center for Theoretical Problems of Physical and Chemical Pharmacology, Russian Academy of Sciences; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology of Ministry of Healthcare of the Russian Federation
																		                	ORCID iD: 0000-0002-8128-7757
				                																			                								Moscow				                	Russian Federation													
References
Supplementary files
 
				
			 
					 
						 
									
 
  
  
  Email this article
			Email this article 

